Hypersensitivity Cross-Reactivity for Ultrasound-Enhancing Agents and COVID-19 Vaccines

J Am Soc Echocardiogr. 2022 May;35(5):523-525. doi: 10.1016/j.echo.2022.02.006. Epub 2022 Feb 16.

Authors

Anish K Desai¹, James Hodovan², J Todd Belcik², Jonathan R Lindner³

Affiliations

¹ Department of Internal Medicine, Oregon Health and Science University, Portland, Oregon.
² Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon.
³ Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon; Oregon National Primate Research Center, Oregon Health and Science University, Portland, Oregon. Electronic address: lindnerj@ohsu.edu.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

COVID-19 Vaccines* / adverse effects
COVID-19*
Contrast Media* / adverse effects
Humans
Hypersensitivity*
SARS-CoV-2
Ultrasonography

Substances

COVID-19 Vaccines
Contrast Media

Grants and funding